XML 101 R78.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation (Expense Recognized) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Amounts charged against income, before income tax benefit $ 6,291 $ 6,357 $ 4,274
Amount of related income tax benefit recognized in income (2,516) (2,529) (1,714)
Total net income/loss impact $ 3,775 $ 3,828 $ 2,560
Long Term Incentive Plan | Restricted stock      
Awards Outstanding      
Non-vested Awards Outstanding (shares) 226,052 232,036 264,655
Granted Awards Outstanding (shares) [1] 175,735 161,011 216,586
Vested Awards Outstanding (shares) [2] (158,469) (156,445) (249,205)
Forfeited Awards Outstanding (shares) (47,350) (10,550)  
Non-vested Awards Outstanding (shares) 195,968 226,052 232,036
Weighted Average Grant Date Fair Value Per Share      
Weighted Average Grant Date Fair Value, Per Share, Non-Vested, Outstanding (USD per share) $ 13.97 $ 12.15 $ 12.64
Weighted Average Grant Date Fair Value Per Share, Granted (USD per share) [1] 14.68 15.06 13.21
Weighted Average Grant Date Fair Value Per Share, Vested (USD per share) [2] 13.89 12.52 13.58
Weighted Average Grant Date Fair Value Per Share, Forfeited (USD per share) 14.42 12.21  
Weighted Average Grant Date Fair Value, Per Share, Non-Vested, Outstanding (USD per share) $ 14.56 $ 13.97 $ 12.15
Weighted average grand date fair value $ 2,600 $ 2,400 $ 2,900
Long Term Incentive Plan | Performance-Based Restricted Stock Awards      
Awards Outstanding      
Non-vested Awards Outstanding (shares) 131,057 0  
Granted Awards Outstanding (shares) 126,000 149,500 [3]  
Forfeited Awards Outstanding (shares) (38,278) (18,443)  
Non-vested Awards Outstanding (shares) 218,779 131,057 0
Weighted Average Grant Date Fair Value Per Share      
Weighted Average Grant Date Fair Value, Per Share, Non-Vested, Outstanding (USD per share) $ 12.87 $ 0.00  
Weighted Average Grant Date Fair Value Per Share, Granted (USD per share) 11.88 12.87 [1]  
Weighted Average Grant Date Fair Value Per Share, Forfeited (USD per share) 12.38 12.82  
Weighted Average Grant Date Fair Value, Per Share, Non-Vested, Outstanding (USD per share) $ 12.39 $ 12.87 $ 0.00
Weighted average grand date fair value $ 1,500 $ 1,900  
Long Term Incentive Plan | Common stock      
Options Outstanding      
Options Outstanding (shares) 2,030,612 1,774,845 1,399,123
Options, Granted (shares) [4] 531,975 620,843 462,374
Options, Exercised (shares) (178,650) [5] (210,638) (51,050)
Options, Forfeited (shares) (96,592) (83,495) (2,005)
Options, Expired (shares) (115,875) (70,943) (33,597)
Options Outstanding (shares) 2,171,470 2,030,612 1,774,845
Options, Exercisable, (shares) [6] 1,492,405    
Options Outstanding, Vested and Expected to Vest (shares) [7] 2,148,754    
Weighted Average Exercise Price Per Share      
Weighted Average Exercise Price, Per Share, Outstanding (USD per share) $ 16.08 $ 16.03 $ 16.74
Weighted Average Exercise Price, Per Share, Granted (USD per share) [4] 14.57 14.74 13.31
Weighted Average Exercise Price, Per Share, Exercised (USD per share) 10.27 [5] 10.07 6.28
Weighted Average Exercise Price, Per Share, Forfeited (USD per share) 14.35 13.41 4.31
Weighted Average Exercise Price, Per Share, Expired (USD per share) 23.58 24.07 23.65
Weighted Average Exercise Price, Per Share, Outstanding (USD per share) 15.87 $ 16.08 $ 16.03
Weighted Average Exercise Price, Per Share, Exercisable (USD per share) [6] 16.49    
Weighted Average Exercise Price, Per Share, Vested and Expected to Vest (USD per share) [7] $ 15.88    
Options, Outstanding, Weighted Average Remaining Contractual Term 6 years 6 months    
Options, Exercisable, Weighted Average Remaining Contractual Term [6] 5 years 7 months 6 days    
Options, Vested and Expected to Vest, Weighted Average Remaining Contractual Term [7] 6 years 6 months    
[1] The grant date fair value per share of the restricted stock awards under the Long Term Incentive Plan was calculated as the fair market value per share of the common stock on the date of grant. During the years ended December 31, 2016, 2015 and 2014, the weighted average grant date fair value of restricted stock awards granted was $2.6 million, $2.4 million, and $2.9 million, respectively
[2] Based upon the respective grant date fair value, the aggregate fair value of restricted stock which vested during the years ended December 31, 2016, 2015 and 2014 was $2.2 million, $2.0 million and $3.4 million, respectively.
[3] During the years ended December 31, 2016 and 2015, the weighted average grant date fair value of performance share awards granted was $1.5 million and $1.9 million, respectively. The grant date fair value of the non-market portion of the performance share awards was calculated as the fair market value of the common stock on the date of grant. For purposes of determining compensation expense for the market portion of the performance share awards, the grant date fair value was estimated using the Monte Carlo valuation model.
[4] During the years ended December 31, 2016, 2015 and 2014, the weighted average grant date fair value of stock options granted was $4.3 million, $5.4 million and $3.2 million, respectively. For purposes of determining compensation expense, the grant date fair value per share of the stock options was estimated using the Black-Scholes option pricing model which requires the use of various assumptions including the expected life of the option, expected dividend rate, expected volatility and risk-free interest rate. Key assumptions used for determining the fair value of stock options granted were as follows: Years Ended December 31, 2016 2015 2014 Expected life (1)5.5 - 6.5 years 5.5 - 6.5 years 5.5 - 6.5 yearsExpected dividend (2)— — —Expected volatility (3)55.1% 59.6% 51.0%Risk-free interest rate (4)1.40% - 1.76% 1.35% - 2.02% 1.63% - 2.19%
[5] During the years ended December 31, 2016 and 2015, the total intrinsic value of stock options that were exercised was $0.9 million and $1.7 million, respectively.
[6] Based upon a fair market value of the common stock as of December 30, 2016 of $18.70 per share, the stock options that are exercisable have an aggregate intrinsic value (equal to the value of in-the-money stock options above their respective exercise price) of $6.5 million.
[7] Based upon a fair market value of the common stock as of December 30, 2016 of $18.70 per share, the stock options that have vested and are expected to vest have an aggregate intrinsic value (equal to the value of in-the-money stock options above their respective exercise price) of $9.2 million.